Editorial Commentary
Uncommon EGFR mutations in non-small-cell lung cancer
Precision Cancer Medicine
2022;
5:
30
(30 September 2022)
Case Report
Giant perivascular spaces in brain: case report with a comprehensive literature review
Precision Cancer Medicine
2022;
5:
29
(30 September 2022)
Case Report
Sporadic mesenteric desmoid-type fibromatosis with “double-hit” T41A and S45P beta-catenin mutation profile: a case report of an extremely rare event—clinically relevant or much ado about nothing?
Precision Cancer Medicine
2022;
5:
28
(30 September 2022)
Review Article
Moving through rare lung cancer histologies: a narrative review on diagnosis and treatment of selected infrequent entities
Precision Cancer Medicine
2022;
5:
27
(30 September 2022)
Review Article
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer
Precision Cancer Medicine
2022;
5:
26
(30 September 2022)
Review Article
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review
Precision Cancer Medicine
2022;
5:
25
(30 September 2022)
Review Article
Clinical implications of liquid biopsies in urogenital tumors: a narrative review
Precision Cancer Medicine
2022;
5:
24
(30 September 2022)
Review Article
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences?
Precision Cancer Medicine
2022;
5:
23
(30 September 2022)
Editorial
How should clinicians manage metastatic non-small cell lung cancer patients with BRAF non-V600E mutations?
Precision Cancer Medicine
2022;
5:
21
(30 September 2022)